PMC Links for Books (Select 4857704) - PMC

Links from Books

Items: 1 to 20 of 25

<< First< Prev

Page of 2

Next >Last >>

Select item 68523641.

Hepatitis B Reactivation in the Treatment of Non-Hodgkin Lymphoma

Matthew Kelling, Lubomir Sokol, Samir Dalia

Cancer Control. 2018 Jan-Dec; 25(1): 1073274818767879. Published online 2018 Apr 1. doi: 10.1177/1073274818767879

PMCID:: PMC6852364

Abstract Article PDF–185K

Select item 59314082.

Fatal Fulminant Hepatitis from Rituximab-induced Hepatitis B Reactivation in a Patient with Follicular Lymphoma: A Case Report and a Brief Review of Literature

Zarak H Khan, Kamran Ilyas, Haider Ghazanfar, Hamza H Khan, Qulsoom Hussain, Sahla Hammad, Ahmed Munir, Rizwan Asim

Cureus. 2018 Mar; 10(3): e2257. Published online 2018 Mar 2. doi: 10.7759/cureus.2257

PMCID:: PMC5931408

Abstract Article PDF–99K

Select item 57399953.

Hepatitis C virus reactivation in patients receiving cancer treatment: a prospective observational study

Harrys A. Torres, Jeff Hosry, Parag Mahale, Minas P. Economides, Ying Jiang, Anna S. Lok

Hepatology. Author manuscript; available in PMC 2019 Jan 1.

Published in final edited form as: Hepatology. 2018 Jan; 67(1): 36–47. Published online 2017 Nov 13. doi: 10.1002/hep.29344

PMCID:: PMC5739995

Abstract Article PDF–455K

Select item 56040944.

Acute Liver Failure Due to Echovirus 9 Associated With Persistent B-Cell Depletion From Rituximab

Kristina L Bajema, Paul D Simonson, Alex L Greninger, Basak Çoruh, Paul S Pottinger, Renuka Bhattacharya, Iris W Liou, Florencia G Jalikis, Corinne L Fligner, Robert M Rakita

Open Forum Infect Dis. 2017 Summer; 4(3): ofx174. Published online 2017 Aug 14. doi: 10.1093/ofid/ofx174

PMCID:: PMC5604094

Abstract Article PDF–395K

Select item 55953275.

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

María Buti, María L. Manzano, Rosa M. Morillas, Montserrat García-Retortillo, Leticia Martín, Martín Prieto, María L. Gutiérrez, Emilio Suárez, Mariano Gómez Rubio, Javier López, Pilar Castillo, Manuel Rodríguez, José M. Zozaya, Miguel A. Simón, Luis E. Morano, José L. Calleja, María Yébenes, Rafael Esteban

PLoS One. 2017; 12(9): e0184550. Published online 2017 Sep 12. doi: 10.1371/journal.pone.0184550

Correction in:: PLoS One. 2018; 13(6): e0199926.

PMCID:: PMC5595327

Abstract Article PDF–1.6M

Select item 54974926.

Recent US Food and Drug Administration Warnings on Hepatitis B Reactivation With Immune-Suppressing and Anticancer Drugs: Just the Tip of the Iceberg?

Adrian M. Di Bisceglie, Anna S. Lok, Paul Martin, Norah Terrault, Robert P. Perrillo, Jay H. Hoofnagle

Hepatology. Author manuscript; available in PMC 2017 Jul 5.

Published in final edited form as: Hepatology. 2015 Feb; 61(2): 703–711. doi: 10.1002/hep.27609

PMCID:: PMC5497492

Abstract Article PDF–430K

Select item 45540527.

Outcome of Hepatitis E Virus Infection in Patients With Inflammatory Arthritides Treated With Immunosuppressants: A French Retrospective Multicenter Study

Hélène Bauer, Cécile Luxembourger, Jacques-Eric Gottenberg, Sophie Fournier, Florence Abravanel, Alain Cantagrel, Emmanuel Chatelus, Pascal Claudepierre, Christophe Hudry, Jacques Izopet, Sylvie Fabre, Guillaume Lefevre, Laurent Marguerie, Antoine Martin, Laurent Messer, Anna Molto, Béatrice Pallot-Prades, Yves-Marie Pers, Anne-Marie Roque-Afonso, Christian Roux, Christelle Sordet, Martin Soubrier, Claire Veissier, Daniel Wendling, Jean-Marie Péron, Jean Sibilia

Medicine (Baltimore) 2015 Apr; 94(14): e675. Published online 2015 Apr 10. doi: 10.1097/MD.0000000000000675

PMCID:: PMC4554052

Abstract Article PDF–129K

Select item 44462358.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 41641059.

Severe Liver Damage and Nonallergic Bronchitis with Eosinophilia in a Patient with Follicular Lymphoma Treated with Bendamustine plus Rituximab

Tatsuro Jo, Kensuke Horio

Case Rep Oncol. 2014 May-Aug; 7(2): 497–502. Published online 2014 Jul 23. doi: 10.1159/000365566

PMCID:: PMC4164105

Abstract Article PDF–605K

Select item 405191310.

Hepatitis C virus reactivation in cancer patients in the era of targeted therapies

Ozan Yazici, Mehmet Ali Nahit Şendur, Sercan Aksoy

World J Gastroenterol. 2014 Jun 14; 20(22): 6716–6724. Published online 2014 Jun 14. doi: 10.3748/wjg.v20.i22.6716

PMCID:: PMC4051913

Abstract Article PDF–1.0M

Select item 402291511.

Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin’s Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study

Fan Yang, Huan-Ling Zhu, Chuan He, Jian-Jun Li, Bing Xiang, Xu Cui, Jie Huang, Jie Ji, Hong-Bing Ma, Ting Liu

Indian J Hematol Blood Transfus. 2014 Jun; 30(2): 97–104. Published online 2012 Oct 30. doi: 10.1007/s12288-012-0195-2

PMCID:: PMC4022915

Abstract Article PDF–387K

Select item 390933612.

Leveraging Administrative Data to Monitor Rituximab Use in 2875 Patients at 42 Freestanding Children's Hospitals across the United States

Marko Kavcic, Brian T. Fisher, Alix E. Seif, Yimei Li, Yuan-Shung Huang, Dana Walker, Richard Aplenc

J Pediatr. Author manuscript; available in PMC 2014 Feb 1.

Published in final edited form as: J Pediatr. 2013 Jun; 162(6): 1252–1258.e1. Published online 2012 Dec 24. doi: 10.1016/j.jpeds.2012.11.038

PMCID:: PMC3909336

Abstract Article PDF–830K

Select item 384794413.

Hepatitis B virus reactivation with rituximab-containing regimen

Yutaka Tsutsumi, Yoshiya Yamamoto, Joji Shimono, Hiroyuki Ohhigashi, Takanori Teshima

World J Hepatol. 2013 Nov 27; 5(11): 612–620. Published online 2013 Nov 27. doi: 10.4254/wjh.v5.i11.612

PMCID:: PMC3847944

Abstract Article PDF–968K

Select item 382399914.

Cholestatic Liver Disease after Rituximab and Adalimumab and the Possible Role of Cross-Reacting Antibodies to Fab 2 Fragments

Joerg Latus, Reinhild Klein, Ina Koetter, Matthias Schwab, Peter Fritz, Martin Kimmel, M. Dominik Alscher, Niko Braun

PLoS One. 2013; 8(11): e78856. Published online 2013 Nov 11. doi: 10.1371/journal.pone.0078856

PMCID:: PMC3823999

Abstract Article PDF–538K

Select item 375645215.

Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients

Ronald F van Vollenhoven, Paul Emery, Clifton O Bingham, III, Edward C Keystone, Roy M Fleischmann, Daniel E Furst, Nicola Tyson, Neil Collinson, Patricia B Lehane

Ann Rheum Dis. 2013 Sep; 72(9): 1496–1502. Published online 2012 Nov 7. doi: 10.1136/annrheumdis-2012-201956

PMCID:: PMC3756452

Abstract Article PDF–271K

Select item 373829016.

Hepatitis B reactivation in a patient with rheumatoid arthritis with antibodies to hepatitis B surface antigen treated with rituximab

E Gigi, T Georgiou, D Mougiou, P Boura, M Raptopoulou-Gigi

Hippokratia. 2013 Jan-Mar; 17(1): 91–93.

PMCID:: PMC3738290

Abstract Article PDF–328K

Select item 373614317.

Hepatitis B Screening, Prophylaxis and Reactivation in the Era of Rituximab-based Chemotherapy

Jorge Méndez-Navarro, Kathleen E. Corey, Hui Zheng, Lydia L. Barlow, Jae Young Jang, Wenyu Lin, Hong Zhao, Run-Xuan Shao, Steven L. McAfee, Raymond T. Chung

Liver Int. Author manuscript; available in PMC 2013 Aug 7.

Published in final edited form as: Liver Int. 2011 Mar; 31(3): 330–339. Published online 2010 Aug 25. doi: 10.1111/j.1478-3231.2010.02332.x

PMCID:: PMC3736143

Abstract Article PDF–1.6M

Select item 372496718.

Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat

Kalliopi Zachou, Alexandros Sarantopoulos, Nikolaos K Gatselis, Themistoklis Vassiliadis, Stella Gabeta, Aggelos Stefos, Asterios Saitis, Panagiota Boura, George N Dalekos

World J Hepatol. 2013 Jul 27; 5(7): 387–392. Published online 2013 Jul 27. doi: 10.4254/wjh.v5.i7.387

PMCID:: PMC3724967

Abstract Article PDF–1.0M

Select item 362285619.

A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience

Myung Jin Oh, Heon Ju Lee

Clin Mol Hepatol. 2013 Mar; 19(1): 51–59. Published online 2013 Mar 25. doi: 10.3350/cmh.2013.19.1.51

PMCID:: PMC3622856

Abstract Article PDF–686K

Select item 346976020.

Hepatitis B virus management to prevent reactivation after chemotherapy: a review

Jessica P. Hwang, John M. Vierling, Andrew D. Zelenetz, Susan C. Lackey, Rohit Loomba

Support Care Cancer. Author manuscript; available in PMC 2012 Nov 1.

Published in final edited form as: Support Care Cancer. 2012 Nov; 20(11): 2999–3008. Published online 2012 Aug 30. doi: 10.1007/s00520-012-1576-7

Correction in:: volume 21 on page 1211

PMCID:: PMC3469760

Abstract Article PDF–63K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 1 to 20 of 25

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity